Omnipaque 140 and Urticaria - a phase IV clinical study of FDA data
Summary:
Urticaria is reported as a side effect among people who take Omnipaque 140 (iohexol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ultravist 300, and have Abdominal pain.
The phase IV clinical study analyzes which people have Urticaria when taking Omnipaque 140. It is created by eHealthMe based on reports of 1,105 people who have side effects when taking Omnipaque 140 from the FDA, and is updated regularly.
What is Omnipaque 140?
Omnipaque 140 has active ingredients of iohexol. eHealthMe is studying from 1,106 Omnipaque 140 users. Check the latest studies of Omnipaque 140.
What is Urticaria?
Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,623 drugs and 2,952 conditions by eHealthMe. Check the latest studies of Urticaria.
1,105 people reported to have side effects when taking Omnipaque 140.
Among them, 38 people (3.44%) have Urticaria.

Among these 38 people:
How long have people been on Omnipaque 140 when they have Urticaria? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Urticaria when taking Omnipaque 140? *
- female: 52.63 %
- male: 47.37 %
What is the age of people who have Urticaria when taking Omnipaque 140? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 6.45 %
- 20-29: 6.45 %
- 30-39: 16.13 %
- 40-49: 22.58 %
- 50-59: 22.58 %
- 60+: 25.81 %
What are other drugs people take besides Omnipaque 140? *
- Ultravist 300: 4 people, 10.53%
- Simvastatin: 3 people, 7.89%
- Ramipril: 3 people, 7.89%
- Morphine: 3 people, 7.89%
- Metoclopramide: 3 people, 7.89%
- Heparin: 3 people, 7.89%
- Clopidogrel: 3 people, 7.89%
- Metoprolol Tartrate: 2 people, 5.26%
- Aspirin: 2 people, 5.26%
- Acetaminophen: 2 people, 5.26%
What are other side effects people have besides Urticaria? *
- Itching: 11 people, 28.95%
- Dyspnea (difficult or laboured breathing): 9 people, 23.68%
- Lip Swelling: 4 people, 10.53%
- Eye Swelling: 4 people, 10.53%
- Rashes (redness): 4 people, 10.53%
- Hypersensitivity: 3 people, 7.89%
- Hoarseness Or Changing Voice: 3 people, 7.89%
- Swallowing Difficulty: 2 people, 5.26%
- Anaphylactoid Reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation): 2 people, 5.26%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 5.26%
What are the existing conditions these people have? *
- Abdominal Pain: 5 people, 13.16%
- Computerised Tomogram Abdomen: 4 people, 10.53%
- Pericarditis - After Heart Attack (inflammation of the pericardium-after heart attack): 3 people, 7.89%
- Abdominal Pain Lower: 2 people, 5.26%
- Swallowing Difficulty: 1 person, 2.63%
- Metastases To Lymph Nodes (cancer spreads to lymph node): 1 person, 2.63%
- Metastases To Lung (cancer spreads to lung): 1 person, 2.63%
- Metastases To Brain (cancer spreads to brain): 1 person, 2.63%
- Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 2.63%
- Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 1 person, 2.63%
* Approximation only. Some reports may have incomplete information.
Do you take Omnipaque 140 and have Urticaria?
- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Omnipaque 140:
- Omnipaque 140 (1,106 reports)
Urticaria treatments and more:
- Urticaria (173,777 reports)
How severe was Urticaria and when was it recovered:
Expand to all the drugs that have ingredients of iohexol:
- Urticaria and drugs with ingredients of iohexol (1,089 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omnipaque 140:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urticaria:
- Urticaria (2,623 drugs)
Browse all the conditions that are associated with Urticaria:
- Urticaria (2,952 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on iohexol (the active ingredients of Omnipaque 140) and Omnipaque 140 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Guaifenesin and Cubicin - a second ago
- Could Profen cause Multiple Fractures? - 15 seconds ago
- Could Xyrem cause Bulimia? - 23 seconds ago
- Could Depakene cause Dehydration? - 24 seconds ago
- Could Fludrocortisone Acetate cause Fall? - 24 seconds ago
- Pain and Boredom - 26 seconds ago
- Could Fluconazole cause Sinusitis - Chronic? - 29 seconds ago
- Could Methionine cause Weakness? - 35 seconds ago
- Could Triazolam cause Tremor? - 37 seconds ago
- Could Flovent cause Skin Warm? - 50 seconds ago